deltatrials
Recruiting OBSERVATIONAL NCT03402919

Comprehensive Assessment of Neurodegeneration and Dementia (COMPASS-ND)

The Comprehensive Assessment of Neurodegeneration and Dementia Study

Sponsor: Alzheimer Society of Canada

Updated 13 times since 2018 Last updated: Jan 15, 2026 Started: Jun 30, 2016 Primary completion: Nov 30, 2023 Completion: Dec 31, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Alzheimer Disease (AD) and Cognitively Unimpaired, this trial is actively recruiting participants. The trial is conducted by Alzheimer Society of Canada and has accumulated 13 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Feb 2018 – ~Apr 2018 · 59 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Nov 2019 · 17 months · monthly snapshot~Nov 2019 – ~Nov 2020 · 12 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Oct 2023 · 22 months · monthly snapshot~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – ~Feb 2026 · 5 months · monthly snapshot~Feb 2026 – present · 5 months · monthly snapshot

Change History

13 versions recorded
  1. Feb 2026 — Present [monthly]

    Recruiting

    Status: UnknownRecruiting

  2. Sep 2025 — Feb 2026 [monthly]

    Unknown

  3. Sep 2024 — Sep 2025 [monthly]

    Unknown

  4. Jul 2024 — Sep 2024 [monthly]

    Unknown

    Status: Unknown StatusUnknown

  5. Oct 2023 — Jul 2024 [monthly]

    Unknown Status

    Status: RecruitingUnknown Status

Show 8 earlier versions
  1. Dec 2021 — Oct 2023 [monthly]

    Recruiting

  2. Jan 2021 — Dec 2021 [monthly]

    Recruiting

  3. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  4. Nov 2019 — Nov 2020 [monthly]

    Recruiting

  5. Jun 2018 — Nov 2019 [monthly]

    Recruiting

  6. May 2018 — Jun 2018 [monthly]

    Recruiting

  7. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NANone

  8. Feb 2018 — Apr 2018 [monthly]

    Recruiting NA

    First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alzheimer Society of Canada
  • Canadian Consortium on Neurodegeneration in Aging
  • Canadian Institutes of Health Research (CIHR)
  • Canadian Nurses Foundation (CNF)
  • Eli Lilly and Company
  • McGill University
  • Michael Smith Foundation for Health Research
  • New Brunswick Health Research Foundation
  • Nova Scotia Health Research Foundation
  • Ontario Brain Institute
  • Pfizer
  • Sanofi
  • Saskatchewan Health Research Foundation
Data source: McGill University

For direct contact, visit the study record on ClinicalTrials.gov .